Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI052347-02
Application #
6766775
Study Section
Experimental Virology Study Section (EVR)
Program Officer
Challberg, Mark D
Project Start
2003-07-01
Project End
2007-12-31
Budget Start
2004-01-01
Budget End
2004-12-31
Support Year
2
Fiscal Year
2004
Total Cost
$345,236
Indirect Cost
Name
Arizona State University-Tempe Campus
Department
Microbiology/Immun/Virology
Type
Schools of Arts and Sciences
DUNS #
943360412
City
Tempe
State
AZ
Country
United States
Zip Code
85287
White, Stacy D; Jacobs, Bertram L (2012) The amino terminus of the vaccinia virus E3 protein is necessary to inhibit the interferon response. J Virol 86:5895-904
White, Stacy D; Conwell, Kip; Langland, Jeffrey O et al. (2011) Use of a negative selectable marker for rapid selection of recombinant vaccinia virus. Biotechniques 50:303-9
Jacobs, Bertram L; Langland, Jeffrey O; Kibler, Karen V et al. (2009) Vaccinia virus vaccines: past, present and future. Antiviral Res 84:1-13
Zhang, Ping; Langland, Jeffrey O; Jacobs, Bertram L et al. (2009) Protein kinase PKR-dependent activation of mitogen-activated protein kinases occurs through mitochondrial adapter IPS-1 and is antagonized by vaccinia virus E3L. J Virol 83:5718-25
Jentarra, Garilyn M; Heck, Michael C; Youn, Jin Won et al. (2008) Vaccinia viruses with mutations in the E3L gene as potential replication-competent, attenuated vaccines: scarification vaccination. Vaccine 26:2860-72
Vijaysri, Sangeetha; Jentarra, Garilyn; Heck, Michael C et al. (2008) Vaccinia viruses with mutations in the E3L gene as potential replication-competent, attenuated vaccines: intra-nasal vaccination. Vaccine 26:664-76